1. Home
  2. RRX vs ALGN Comparison

RRX vs ALGN Comparison

Compare RRX & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Regal Rexnord Corporation

RRX

Regal Rexnord Corporation

HOLD

Current Price

$150.90

Market Cap

9.0B

Sector

N/A

ML Signal

HOLD

Logo Align Technology Inc.

ALGN

Align Technology Inc.

HOLD

Current Price

$165.42

Market Cap

10.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RRX
ALGN
Founded
1955
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.0B
10.2B
IPO Year
1987
N/A

Fundamental Metrics

Financial Performance
Metric
RRX
ALGN
Price
$150.90
$165.42
Analyst Decision
Buy
Buy
Analyst Count
10
14
Target Price
$169.80
$188.92
AVG Volume (30 Days)
861.1K
1.6M
Earning Date
10-29-2025
10-29-2025
Dividend Yield
0.91%
N/A
EPS Growth
22.48
N/A
EPS
3.87
5.16
Revenue
$5,872,300,000.00
$3,982,622,000.00
Revenue This Year
N/A
$2.58
Revenue Next Year
$3.93
$3.41
P/E Ratio
$39.45
$31.75
Revenue Growth
N/A
0.56
52 Week Low
$90.56
$122.00
52 Week High
$173.46
$246.19

Technical Indicators

Market Signals
Indicator
RRX
ALGN
Relative Strength Index (RSI) 57.68 78.37
Support Level $144.67 $144.00
Resistance Level $157.25 $166.61
Average True Range (ATR) 5.56 4.65
MACD 1.25 1.60
Stochastic Oscillator 60.27 94.81

Price Performance

Historical Comparison
RRX
ALGN

About RRX Regal Rexnord Corporation

Regal Rexnord Corp is in the engineering and manufacturing of industrial powertrain solutions, power transmission components, electric motors, electronic controls, air-moving products, and specialty electrical components and systems, serving customers around the world. The four operating segments include Commercial Systems, Industrial Systems, Climate Solutions, and Motion Control Solutions.

About ALGN Align Technology Inc.

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Share on Social Networks: